FDA approves pancreatic cancer drug Abraxane

US-based Celgene Corporation's chemotherapy drug Abraxane has received approval by the US Food and Drug Administration (FDA) for the treatment of pancreatic cancer, in combination with gemcitabine.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news